|
Market Cap | 0.83M | EPS (ttm) | -14.42 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -20.69% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -111.83% |
Dividend | - | Sales Q/Q | - |
Insider Own | 25.72% | Inst Own | 0.33% |
Insider Trans | 0.00% | Inst Trans | -18.21% |
Short Float | 0.91% | Earnings | May 13/a |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 28.66K | 52W Range | 1.98 - 11.77 |
|
|
|
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA. |
|
|
|
Market Cap | 1.18M | EPS (ttm) | -5.02 |
P/E | - | EPS this Y | 12.09% |
Forward P/E | - | EPS next Y | 32.33% |
PEG | - | EPS past 5Y | 38.94% |
P/S | 2.06 | EPS next 5Y | - |
P/B | 0.15 | EPS Q/Q | -10.91% |
Dividend | - | Sales Q/Q | - |
Insider Own | 13.01% | Inst Own | 1.98% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 3.04% | Earnings | Feb 14/a |
Analyst Recom | 2.00 | Target Price | 13.25 |
Avg Volume | 389.59K | 52W Range | 0.80 - 5.00 |
|
|
|
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA. |
|
|
|
Market Cap | 2.24M | EPS (ttm) | -1.19 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 35.17% |
P/S | 2.87 | EPS next 5Y | - |
P/B | 1.12 | EPS Q/Q | 94.84% |
Dividend | - | Sales Q/Q | -59.46% |
Insider Own | 8.65% | Inst Own | 39.77% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.29% | Earnings | Feb 16/a |
Analyst Recom | 1.00 | Target Price | 5.01 |
Avg Volume | 105.41K | 52W Range | 0.62 - 3.85 |
|
|
|
KWESST Micro Systems, Inc. provides defense and security services. The firm's technology portfolio includes its proprietary MISST system, Micro Integrated Systems and Software Technology. The company was founded by Jeff Macleod on November 28, 2017, and is headquartered in Ottawa, Canada. |
|
| |
|
Market Cap | 37.32M | EPS (ttm) | -0.00 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 1.83 | EPS Q/Q | -422.46% |
Dividend | - | Sales Q/Q | - |
Insider Own | 54.10% | Inst Own | 6.01% |
Insider Trans | 0.00% | Inst Trans | 5.83% |
Short Float | 0.11% | Earnings | May 14/a |
Analyst Recom | - | Target Price | - |
Avg Volume | 97.50K | 52W Range | 1.37 - 19.75 |
|
|
|
Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is headquartered in Jackson, WY. |
|
|
|
Market Cap | 0.94M | EPS (ttm) | -0.72 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 46.93 | EPS next 5Y | - |
P/B | 115.93 | EPS Q/Q | -78.19% |
Dividend | - | Sales Q/Q | - |
Insider Own | 36.91% | Inst Own | 6.72% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 3.33% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 14.00 |
Avg Volume | 52.65K | 52W Range | 0.65 - 17.00 |
|
|
|
Lucy Scientific Discovery, Inc. is an early-stage company, which engages in the manufacture of psychotropics contracts. It focuses on the research, development, and manufacture of psychotropics-based medicines. Its products include raw materials, crude extracts, targeted formulations, white and private label products, and single molecule fractions. The company was founded on February 17, 2017 and is headquartered in Victoria, Canada. |
|
| |
|
Market Cap | 18.68M | EPS (ttm) | -4.59 |
P/E | - | EPS this Y | 34.26% |
Forward P/E | - | EPS next Y | 27.51% |
PEG | - | EPS past 5Y | 20.27% |
P/S | 12.29 | EPS next 5Y | 15.20% |
P/B | 1.07 | EPS Q/Q | -44.50% |
Dividend | - | Sales Q/Q | -76.12% |
Insider Own | 39.19% | Inst Own | 25.61% |
Insider Trans | -0.08% | Inst Trans | 7.82% |
Short Float | 6.07% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 22.50 |
Avg Volume | 27.79K | 52W Range | 2.41 - 4.55 |
|
|
|
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McKew John C. | Chief Scientific Officer | Apr 03 '24 | Sale | 2.77 | 2,214 | 6,144 | 17,153 | Apr 03 05:10 PM | McKew John C. | Chief Scientific Officer | Feb 06 '24 | Sale | 3.03 | 438 | 1,328 | 18,403 | Feb 07 05:22 PM | McKew John C. | Chief Scientific Officer | Aug 02 '23 | Sale | 3.21 | 3,407 | 10,919 | 18,707 | Aug 03 04:58 PM |
|
|
|
|
Market Cap | 52.90M | EPS (ttm) | -0.04 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -23282.61% |
Dividend | - | Sales Q/Q | - |
Insider Own | 74.51% | Inst Own | 10.84% |
Insider Trans | 0.00% | Inst Trans | 74.96% |
Short Float | 0.70% | Earnings | Feb 22/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 12.96K | 52W Range | 1.50 - 11.40 |
|
|
|
Aeries Technology Inc. engages in the provision of management consultancy services for private equity sponsors and their portfolio companies. It specializes in technology services and solutions, business process management, and digital transformation initiatives. The company was founded by Raman Kumar and Sudhir Panikasser in 2012 is headquartered in Singapore. |
|
| |
|
Market Cap | 11.00M | EPS (ttm) | -9.60 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.03 | EPS next 5Y | 15.00% |
P/B | 0.10 | EPS Q/Q | -415.41% |
Dividend | - | Sales Q/Q | -28.46% |
Insider Own | 15.95% | Inst Own | 56.74% |
Insider Trans | 0.00% | Inst Trans | -3.74% |
Short Float | 0.86% | Earnings | May 08/a |
Analyst Recom | 5.00 | Target Price | 37.00 |
Avg Volume | 34.22K | 52W Range | 1.61 - 11.49 |
|
|
|
Delta Apparel, Inc. engages in designing, manufacturing, sourcing, and marketing lifestyle branded active wear apparel and headwear. It operates through the Delta Group and Salt Life Group segments. The Delta Group segment consists of the business units DTG2Go, Delta Activewear, and Soffe, which are primarily focused on core activewear styles. The Salt Life Group segment includes lifestyle brands focused on a range of apparel garments, headwear, and related accessories to meet consumer preferences and fashion trends, along with Salt Life and Coast business units. The company was founded in 1999 and is headquartered in Duluth, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Encalada Arjona Carlos Enrique | V.P. of Manufacturing | Dec 28 '23 | Option Exercise | 0.00 | 2,500 | 0 | 4,654 | Jan 02 02:36 PM | Stillwell Jeffery Neil | President, Salt Life Group | Dec 28 '23 | Option Exercise | 0.00 | 5,000 | 0 | 64,157 | Jan 02 04:15 PM | HUMPHREYS ROBERT W | Chairman and CEO | Dec 28 '23 | Option Exercise | 0.00 | 42,000 | 0 | 500,902 | Jan 02 03:20 PM | Chang Lauren Satterfield | Deputy GC & Corp. Secretary | Dec 28 '23 | Option Exercise | 0.00 | 1,750 | 0 | 1,750 | Jan 02 02:26 PM | Bubanich Nancy P | VP & Chief Accounting Officer | Dec 28 '23 | Option Exercise | 0.00 | 1,750 | 0 | 5,070 | Jan 02 02:43 PM |
|
|
|
|
Market Cap | 17.20M | EPS (ttm) | -2.40 |
P/E | - | EPS this Y | -395.59% |
Forward P/E | 1.96 | EPS next Y | 411.11% |
PEG | - | EPS past 5Y | -227.20% |
P/S | 0.14 | EPS next 5Y | 30.00% |
P/B | - | EPS Q/Q | -256.60% |
Dividend | - | Sales Q/Q | 27.56% |
Insider Own | 75.61% | Inst Own | 15.80% |
Insider Trans | -0.30% | Inst Trans | 157.88% |
Short Float | 27.63% | Earnings | May 13/a |
Analyst Recom | 3.00 | Target Price | 5.67 |
Avg Volume | 552.99K | 52W Range | 0.44 - 6.88 |
|
|
|
LuxUrban Hotels Inc. engages in the acquisition and management of hotel units. The company was founded on December 13, 2019 and is headquartered in Miami, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ferdinand Brian | Chairman & Co-CEO | Dec 13 '23 | Buy | 4.56 | 25,000 | 114,050 | 225,825 | Dec 14 08:30 AM | Ferdinand Brian | Chairman & Co-CEO | Dec 01 '23 | Sale | 4.45 | 14,219 | 63,275 | 15,347,917 | Dec 04 07:00 AM | Ferdinand Brian | Chairman & Co-CEO | Nov 30 '23 | Sale | 4.46 | 62,000 | 276,520 | 15,362,136 | Dec 04 07:00 AM | Ferdinand Brian | Chairman & Co-CEO | Nov 22 '23 | Sale | 5.21 | 6,556 | 34,157 | 15,424,136 | Nov 24 05:13 PM | Ferdinand Brian | Chairman & Co-CEO | Nov 21 '23 | Sale | 5.10 | 38,277 | 195,213 | 15,430,692 | Nov 24 05:13 PM |
|
|
|
|
Market Cap | 45.82M | EPS (ttm) | -0.25 |
P/E | - | EPS this Y | 17.50% |
Forward P/E | - | EPS next Y | 54.55% |
PEG | - | EPS past 5Y | 26.38% |
P/S | 1527.18 | EPS next 5Y | 35.00% |
P/B | 1.68 | EPS Q/Q | -83.96% |
Dividend | - | Sales Q/Q | - |
Insider Own | 4.92% | Inst Own | 18.97% |
Insider Trans | 0.09% | Inst Trans | 1.12% |
Short Float | 3.43% | Earnings | May 15/a |
Analyst Recom | 1.00 | Target Price | 3.00 |
Avg Volume | 414.91K | 52W Range | 0.42 - 1.76 |
|
|
|
Aqua Metals, Inc. engages in reinventing metal recycling technologies. Its patented technology, AquaRefining, replaces polluting furnaces and hazardous chemicals with electricity-powered electroplating to recover valuable metals and materials from spent batteries with higher purity, lower emissions, and minimal waste. The company was founded by Stephen R. Clarke, Thomas Murphy, and Selwyn Mould on June 20, 2014 and is headquartered in Reno, NV. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DIVITO VINCENT L | Director | Nov 17 '23 | Buy | 0.89 | 5,000 | 4,450 | 339,590 | Nov 20 06:30 AM | SMITH EDWARD J | Director | Jul 19 '23 | Buy | 1.10 | 90,500 | 99,550 | 309,050 | Jul 20 04:34 PM | Zhang Peifang | Director | Jul 19 '23 | Buy | 1.10 | 72,900 | 80,190 | 251,050 | Jul 20 04:33 PM | DIVITO VINCENT L | Director | Jul 19 '23 | Buy | 1.10 | 9,000 | 9,900 | 334,590 | Jul 20 04:32 PM |
|
|
|